Professor Paul Turner
Contact information
Podcast interview
Microbiology in the tropics
Infectious diseases are prevalent in Cambodia, a country that is struggling with poor infrastructure. Streptococcus pneumoniae causes the most severe form of pneumonia and is now targeted by the pneumococcal conjugate vaccine. Dr Paul Turner is studying the effect of this vaccine in field conditions in SE Asia, as well as other direct applications such as the evaluation of a new diagnostic test for Typhoid and interventions to reduce the burden of infections acquired within hospitals.
Paul Turner
MB BS, PhD, FRCPCH, FRCPath
Professor of Paediatric Microbiology
- Senior Clinical Research Fellow
- Consultant in Microbiology
- Director of the Cambodia Oxford Medical Research Unit
- Principal Investigator for the ACORN Clinical AMR Surveillance Network
Clinical microbiologist with a focus on paediatric infections
Paul Turner is based at the Cambodia-Oxford Medical Research Unit (COMRU), Angkor Hospital for Children in Siem Reap, Cambodia.
He co-leads the ACORN clinical AMR surveillance network with OUCRU-Hanoi's Rogier van Doorn.
His research interests include:
- Antimicrobial resistance surveillance and control;
- Paediatric healthcare associated infections;
- Pneumococcal colonisation and disease and the impact of pneumococcal vaccines;
- Utilisation of bacterial colonisation data.
His non-research work focuses on development of human and laboratory capacity for diagnostic microbiology in low-resource settings, with a focus on improving laboratory informatics.
Recent publications
-
Practical Methods to Permit the Analysis of Host Biomarkers in Resource-Limited Settings.
Chandna A. et al, (2022), The American journal of tropical medicine and hygiene
-
A Streptococcus pneumoniae lineage usually associated with pneumococcal conjugate vaccine (PCV) serotypes is the most common cause of serotype 35B invasive disease in South Africa, following routine use of PCV.
Ndlangisa KM. et al, (2022), Microbial genomics, 8
-
Facilitating safe discharge through predicting disease progression in moderate COVID-19: a prospective cohort study to develop and validate a clinical prediction model in resource-limited settings.
Chandna A. et al, (2022), Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
-
World Health Organization (WHO) standard methods for pneumococcal carriage studies.
Turner P. et al, (2022), Clin Infect Dis
-
Pneumococcal within-host diversity during colonisation, transmission and treatment
Tonkin-Hill G. et al, (2022)